:max_bytes(150000):strip_icc()/GettyImages-2169095535-e0b1ad5cf70a42df9bea997a5b976e20.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Stock Slips as CEO Faces Senate Inquiry Into Wegovy, Ozempic Prices")
Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker’s…
Read More »Wegovy
Surging demand for new medicines to treat obesity and diabetes make it hard for many patients to get them. Michael…
Read More »
GLP-1 drugs, like Wegovy and Ozempic, may not be good only for diabetes and weight-loss. They are also showing promise…
Read More »
Cheaper copycat versions of blockbuster weight loss drugs are flooding the market. Guido Mieth/Getty Images hide caption toggle caption Guido…
Read More »:max_bytes(150000):strip_icc()/GettyImages-1586472196-bcba05b3a5d644c488138996564d538c.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Rises as Wegovy Is Approved in China")
Key Takeaways American depositary receipts (ADRs) of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular…
Read More »